Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

NARecruitingINTERVENTIONAL
Enrollment

2,032

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2027

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Dual-Energy Contrast-Enhanced Spectral Mammography (CESM)

In addition to their standard, digital breast tomosynthesis mammogram (DBT) performed at their regular screening visits, all participants will also receive a contrast-enhanced spectral mammography (CESM). These same diagnostic tests, both the DBT and CESM, with be repeated at 1 year post study entry for all participants. At year 2 post study entry, all participants will return to their usual breast screening exams and no longer received a CESM.

Trial Locations (10)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

22911

RECRUITING

University of Virginia, Charlottesville

27834

RECRUITING

Carolina Breast Imaging Specialists, Greenville

32159

ACTIVE_NOT_RECRUITING

Lake Medical Imaging, The Villages

33486

RECRUITING

Boca Raton Regional Hospital - Christine E. Lynn Women's Health and Wellness Institute, Boca Raton

35233

RECRUITING

University of Alabama, Birmingham, Birmingham

48202

RECRUITING

Henry Ford Health, Detroit

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

N6A 4V2

RECRUITING

St. Joseph's Hospital, London

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

collaborator

Breast Cancer Research Foundation

OTHER

lead

American College of Radiology

OTHER